Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Marc D. Binder(University of Antwerp), Christoph U. Correll(German Centre for Cardiovascular Research), Ruud van Winkel(Maastricht University), Johan Detraux(Catholic University of America), Weiping Yu(KU Leuven)
Cited by 1,120
Related Papers
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
|Molecular Psychiatry|2021|3.6k
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
|World Psychiatry|2011|2.5k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls
|World Psychiatry|2017|1.7k
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
|The Lancet Psychiatry|2019|1.5k